As reported in a study on hereditary large vessel diseases, FLNA's dysfunction disrupts the activities of transforming growth factor-β (TGF-β) signaling pathways, extracellular matrix and smooth muscle contractile apparatus, thus resulting in structural damage to AD (38). This evidence concerns the gene TGFB1 and Alzheimer disease.